Suspension of trading

Income Statement Catalyst Pharmaceuticals, Inc.

Stocks

CPRX

US14888U1016

Pharmaceuticals

Market Closed - Nasdaq 16:00:00 2026-07-14 EDT			5-day change	1st Jan Change
31.49 ^USD	+0.03%		-.--%	+34.92%

08-03	CDP targets new defense acquisitions after T-Defence deal - sources	RE
08-03	CDP's new chapter, a push for global companies	AN

c875c41a0d08cdd594497f67c1.meuHCVCp6w51qezxaozqpj5nqw0FpZsmeHk7_NaTQRc.4MbkPRyZkVon3ZXcPP2O0VoC9FpR6rYXEkFRjLfpDG3yh-FFOuKzeQzctQ

Published financial data: CATALYST PHARMACEUTICALS, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Revenues	141M	214M	398M	492M	589M
Total Revenues	141M	214M	398M	492M	589M
Cost of Goods Sold, Total	38.82M	54.18M	145M	81.49M	99.96M
Gross Profit	102M	160M	253M	410M	489M
Selling General & Admin Expenses, Total	49.63M	58.18M	134M	178M	194M
R&D Expenses	-	-	-	-	-
Amortization of Goodwill and Intangible Assets - (IS)	-	-	32.56M	37.38M	37.5M
Other Operating Expenses, Total	49.63M	58.18M	166M	215M	231M
Operating Income	52.38M	102M	86.81M	195M	258M
Interest And Investment Income	282K	3.64M	4.68M	16.06M	24.76M
Net Interest Expenses	282K	3.64M	4.68M	16.06M	24.76M
Other Non Operating Income (Expenses)	-	-	-	-	-
EBT, Excl. Unusual Items	52.67M	105M	91.49M	211M	283M
Restructuring Charges	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-	-762K	3.02M	5.08M	972K
Legal Settlements	-	-	-	-	-
EBT, Incl. Unusual Items	52.67M	105M	94.51M	216M	284M
Income Tax Expense	13.18M	21.64M	23.1M	52.37M	69.19M
Earnings From Continuing Operations	39.48M	83.08M	71.41M	164M	214M
Net Income to Company	39.48M	83.08M	71.41M	164M	214M
Net Income - (IS)	39.48M	83.08M	71.41M	164M	214M
Net Income to Common Incl Extra Items	39.48M	83.08M	71.41M	164M	214M
Net Income to Common Excl. Extra Items	39.48M	83.08M	71.41M	164M	214M
Per Share Items
Net EPS - Basic	0.38	0.8	0.67	1.38	1.75
Basic EPS - Continuing Operations	0.38	0.8	0.67	1.38	1.75
Basic Weighted Average Shares Outstanding	103M	103M	106M	118M	122M
Net EPS - Diluted	0.37	0.75	0.63	1.31	1.68
Diluted EPS - Continuing Operations	0.37	0.75	0.63	1.31	1.68
Diluted Weighted Average Shares Outstanding	108M	111M	114M	125M	127M
Normalized Basic EPS	0.32	0.64	0.54	1.11	1.44
Normalized Diluted EPS	0.31	0.59	0.5	1.06	1.39
Supplemental Items
EBITDA	52.58M	103M	120M	233M	296M
EBITA	52.38M	103M	119M	233M	295M
EBIT	52.38M	102M	86.81M	195M	258M
EBITDAR	52.98M	104M	120M	233M	296M
Total Revenues (As Reported)	141M	214M	398M	492M	589M
Effective Tax Rate - (Ratio)	25.03	20.66	24.44	24.22	24.4
Current Domestic Taxes	-	16.74M	40.91M	61.83M	75.95M
Total Current Taxes	3.87M	16.74M	40.91M	61.83M	75.95M
Deferred Domestic Taxes	-	4.9M	-17.8M	-9.45M	-6.76M
Total Deferred Taxes	9.32M	4.9M	-17.8M	-9.45M	-6.76M
Normalized Net Income	32.92M	65.93M	57.18M	132M	177M
Supplemental Operating Expense Items
Advertising Expense	2.9M	3.3M	9.1M	10M	13M
Selling and Marketing Expenses	2.9M	3.3M	9.1M	10M	13M
General and Administrative Expenses	-	-	-	-	-
Research And Development Expense From Footnotes	16.94M	19.79M	93.15M	12.65M	12.71M
Net Rental Expense, Total	400K	431K	431K	431K	431K
Stock-Based Comp., COGS (Total)	1.61M	1.73M	1.48M	1.78M	2.2M
Stock-Based Comp., R&D Exp. (Total)	-	-	-	-	-
Stock-Based Comp., G&A Exp. (Total)	-	-	-	-	-
Stock-Based Comp., SG&A Exp. (Total)	4.46M	6.18M	12.77M	20.47M	22.57M
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	6.07M	7.91M	14.25M	22.25M	24.78M

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Assets
Cash And Equivalents	171M	298M	138M	518M	709M
Short Term Investments	19.82M	-	-	-	-
Total Cash And Short Term Investments	191M	298M	138M	518M	709M
Accounts Receivable, Total	6.72M	10.79M	53.65M	65.49M	126M
Other Receivables	-	-	-	-	1.79M
Total Receivables	6.72M	10.79M	53.65M	65.49M	128M
Inventory	7.87M	6.8M	15.64M	19.54M	37.17M
Prepaid Expenses	3.92M	4.23M	12.05M	20M	17.39M
Other Current Assets, Total	327K	577K	351K	1.03M	2.04M
Total Current Assets	210M	321M	219M	624M	894M
Gross Property Plant And Equipment	4.25M	4.02M	4.43M	4.7M	4.47M
Accumulated Depreciation	-275K	-406K	-723K	-1.12M	-1.5M
Net Property Plant And Equipment	3.98M	3.62M	3.7M	3.58M	2.97M
Long-term Investments	-	-	16.49M	21.56M	22.54M
Other Intangibles, Total	-	32.47M	194M	157M	132M
Deferred Tax Assets Long-Term	23.7M	18.74M	36.54M	45.98M	52.77M
Other Long-Term Assets, Total	9K	9K	-	-	-
Total Assets	238M	376M	470M	851M	1.1B
Liabilities
Accounts Payable, Total	2.77M	3.98M	14.8M	16.59M	11.2M
Accrued Expenses, Total	21.95M	27.83M	40.29M	53.85M	61.66M
Current Portion of Leases	308K	337K	369K	402K	437K
Current Income Taxes Payable	79K	8.7M	729K	894K	1.4M
Other Current Liabilities	1.96M	16.75M	19.88M	48.94M	72.46M
Total Current Liabilities	27.06M	57.59M	76.06M	121M	147M
Long-Term Leases	3.89M	3.56M	3.19M	2.79M	2.35M
Other Non Current Liabilities	-	14.06M	2.98M	315K	209K
Total Liabilities	30.96M	75.21M	82.23M	124M	150M
Common Stock, Total	103K	105K	107K	121K	123K
Additional Paid In Capital	233M	250M	266M	442M	480M
Retained Earnings	-26.31M	49.86M	121M	285M	474M
Comprehensive Income and Other	-148K	24K	14K	64K	-
Total Common Equity	207M	300M	388M	728M	954M
Total Equity	207M	300M	388M	728M	954M
Total Liabilities And Equity	238M	376M	470M	851M	1.1B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	103M	106M	118M	121M	122M
ECS Total Common Shares Outstanding	103M	105M	107M	121M	123M
Book Value / Share	2.01	2.85	3.62	6.02	7.79
Tangible Book Value	207M	268M	194M	571M	823M
Tangible Book Value Per Share	2.01	2.55	1.81	4.72	6.71
Total Debt	4.2M	3.89M	3.56M	3.19M	2.79M
Net Debt	-187M	-295M	-134M	-514M	-706M
Debt Equivalent Oper. Leases	3.2M	3.45M	3.45M	3.45M	3.45M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	1.77M	-	1.91M	6.52M	17.14M
Inventories - Work In Process, Total	5.17M	5.54M	4.57M	3.44M	3.87M
Inventories - Finished Goods, Total	929K	1.26M	9.16M	9.58M	16.16M
Machinery, Total	254K	273K	494K	1.05M	1.11M
Full Time Employees	76	82	167	181	182

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Net Income	39.48M	83.08M	71.41M	164M	214M
Depreciation & Amortization - CF	192K	141K	316K	397K	375K
Amortization of Goodwill and Intangible Assets - (CF)	-	1.1M	32.56M	37.38M	37.5M
Depreciation & Amortization, Total	192K	1.24M	32.88M	37.77M	37.87M
(Gain) Loss on Sale of Investments - (CF)	-	762K	-3.02M	-5.08M	-972K
Asset Writedown & Restructuring Costs	-	-	81.51M	-	-
Stock-Based Compensation (CF)	6.07M	7.91M	14.25M	22.25M	24.78M
Other Operating Activities, Total	9.6M	9.33M	-16.11M	-9.94M	-6.44M
Change In Accounts Receivable	-632K	-3.82M	-43.08M	-11.96M	-61M
Change In Inventories	-3.22M	1.06M	-4.74M	-3.9M	-18.09M
Change In Accounts Payable	-1.49M	1.21M	10.82M	1.8M	-5.39M
Change in Other Net Operating Assets	10.36M	15.28M	-330K	44.98M	23.59M
Cash from Operations	60.37M	116M	144M	240M	209M
Capital Expenditure	-1.02M	-29K	-199M	-556K	-58K
Sale (Purchase) of Intangible assets	-	-10M	-81.51M	-	-
Investment in Marketable and Equity Securities, Total	-10M	19.24M	-13.46M	-	-
Cash from Investing	-11.02M	9.21M	-294M	-556K	-58K
Issuance of Common Stock	4.1M	9.57M	2.79M	155M	14.67M
Repurchase of Common Stock	-12.24M	-7.14M	-982K	-668K	-27.07M
Other Financing Activities, Total	-	-738K	-12.67M	-13.18M	-4.59M
Cash from Financing	-8.14M	1.69M	-10.86M	141M	-16.99M
Net Change in Cash	41.21M	127M	-161M	380M	192M
Supplemental Items
Cash Interest Paid	-	-	705K	1.4M	466K
Cash Income Tax Paid (Refund)	3M	7.67M	50.46M	68.45M	71.99M
Levered Free Cash Flow	42.14M	89.7M	-219M	202M	171M
Unlevered Free Cash Flow	42.14M	89.7M	-219M	202M	171M
Change In Net Working Capital	-4.15M	-26.93M	40.84M	-20.22M	52.36M

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Profitability
Return on Assets	15.22	20.75	12.83	18.46	16.48
Return on Total Capital	17.2	24.7	15.6	21.73	19.09
Return On Equity %	20.98	32.76	20.75	29.38	25.49
Return on Common Equity	20.98	32.76	20.75	29.38	25.49
Margin Analysis
Gross Profit Margin %	72.44	74.71	63.56	83.43	83.03
SG&A Margin	35.24	27.16	33.58	36.15	32.9
EBITDA Margin %	37.33	48.12	30.06	47.36	50.2
EBITA Margin %	37.2	48.06	29.98	47.28	50.13
EBIT Margin %	37.2	47.54	21.8	39.68	43.77
Income From Continuing Operations Margin %	28.03	38.79	17.93	33.33	36.39
Net Income Margin %	28.03	38.79	17.93	33.33	36.39
Net Avail. For Common Margin %	28.03	38.79	17.93	33.33	36.39
Normalized Net Income Margin	23.37	30.78	14.36	26.84	29.98
Levered Free Cash Flow Margin	29.92	41.88	-55.12	41.01	29.09
Unlevered Free Cash Flow Margin	29.92	41.88	-55.12	41.01	29.09
Asset Turnover
Asset Turnover	0.65	0.7	0.94	0.74	0.6
Fixed Assets Turnover	68.6	56.42	108.8	134.96	179.68
Receivables Turnover (Average Receivables)	21.42	24.46	12.36	8.25	6.14
Inventory Turnover (Average Inventory)	6.2	7.38	12.93	4.63	3.53
Short Term Liquidity
Current Ratio	7.76	5.57	2.88	5.17	6.08
Quick Ratio	7.32	5.37	2.51	4.83	5.69
Operating Cash Flow to Current Liabilities	2.23	2.02	1.89	1.99	1.42
Days Sales Outstanding (Average Receivables)	17.04	14.92	29.54	44.34	59.48
Days Outstanding Inventory (Average Inventory)	58.86	49.43	28.23	79.01	103.53
Average Days Payable Outstanding	30.49	23.17	22.25	67.27	43.14
Cash Conversion Cycle (Average Days)	45.41	41.19	35.52	56.08	119.87
Long Term Solvency
Total Debt/Equity	2.03	1.3	0.92	0.44	0.29
Total Debt / Total Capital	1.99	1.28	0.91	0.44	0.29
LT Debt/Equity	1.88	1.18	0.82	0.38	0.25
Long-Term Debt / Total Capital	1.85	1.17	0.81	0.38	0.25
Total Liabilities / Total Assets	13.02	20.02	17.49	14.54	13.56
Total Debt / EBITDA	0.08	0.04	0.03	0.01	0.01
Net Debt / EBITDA	-3.53	-2.85	-1.12	-2.2	-2.39
Total Debt / (EBITDA - Capex)	0.08	0.04	-0.05	0.01	0.01
Net Debt / (EBITDA - Capex)	-3.6	-2.85	1.71	-2.21	-2.39
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	18.27	52.1	85.9	23.49	19.78
Gross Profit, 1 Yr. Growth %	19.26	56.86	58.16	62.09	19.2
EBITDA, 1 Yr. Growth %	27.01	96.05	16.12	94.58	26.94
EBITA, 1 Yr. Growth %	26.83	96.5	15.97	94.76	27
EBIT, 1 Yr. Growth %	26.83	94.4	-14.75	124.77	32.11
Earnings From Cont. Operations, 1 Yr. Growth %	-47.35	110.42	-14.05	129.5	30.78
Net Income, 1 Yr. Growth %	-47.35	110.42	-14.05	129.5	30.78
Normalized Net Income, 1 Yr. Growth %	25.73	100.28	-13.27	130.84	33.79
Diluted EPS Before Extra, 1 Yr. Growth %	-47.89	102.7	-16	107.94	28.24
Accounts Receivable, 1 Yr. Growth %	4.67	60.51	397.1	22.06	93.17
Inventory, 1 Yr. Growth %	69.21	-13.53	129.89	24.91	90.19
Net Property, Plant and Equip., 1 Yr. Growth %	2.96K	-9.03	2.38	-3.21	-17.08
Total Assets, 1 Yr. Growth %	23.62	57.97	25.15	81.11	29.66
Tangible Book Value, 1 Yr. Growth %	21.95	29.55	-27.66	194.56	44.07
Common Equity, 1 Yr. Growth %	21.95	45.25	29.11	87.59	31.15
Cash From Operations, 1 Yr. Growth %	34.06	92.22	23.74	67	-12.98
Capital Expenditures, 1 Yr. Growth %	9.18K	-97.16	1.88K	-99.72	-89.57
Levered Free Cash Flow, 1 Yr. Growth %	45.49	112.87	-344.72	-191.87	-15.03
Unlevered Free Cash Flow, 1 Yr. Growth %	45.49	112.87	-344.72	-191.87	-15.03
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	17.33	34.12	68.15	51.51	21.62
Gross Profit, 2 Yr. CAGR %	21.85	36.78	57.51	60.11	39.01
EBITDA, 2 Yr. CAGR %	28.43	57.8	50.88	50.31	57.16
EBITA, 2 Yr. CAGR %	28.3	57.87	50.96	50.29	57.27
EBIT, 2 Yr. CAGR %	28.3	57.02	28.73	38.42	72.32
Earnings From Cont. Operations, 2 Yr. CAGR %	11.29	5.26	34.49	40.45	73.24
Net Income, 2 Yr. CAGR %	11.29	5.26	34.49	40.45	73.24
Normalized Net Income, 2 Yr. CAGR %	25.56	58.68	31.8	42.01	75.74
Diluted EPS Before Extra, 2 Yr. CAGR %	11.06	2.78	30.49	32.16	63.3
Accounts Receivable, 2 Yr. CAGR %	-20.12	29.62	182.47	146.32	53.54
Inventory, 2 Yr. CAGR %	100.55	20.96	40.99	69.46	54.13
Net Property, Plant and Equip., 2 Yr. CAGR %	99.03	427.48	-3.49	-0.46	-10.41
Total Assets, 2 Yr. CAGR %	45.46	39.74	40.61	50.55	53.24
Tangible Book Value, 2 Yr. CAGR %	53.63	25.69	-3.19	45.97	106.01
Common Equity, 2 Yr. CAGR %	53.63	33.09	36.94	55.63	56.85
Cash From Operations, 2 Yr. CAGR %	32.07	60.53	54.23	43.75	20.55
Capital Expenditures, 2 Yr. CAGR %	633.05	62.37	1.29K	-76.45	-98.29
Levered Free Cash Flow, 2 Yr. CAGR %	35.66	75.98	128.23	49.94	-11.65
Unlevered Free Cash Flow, 2 Yr. CAGR %	35.66	75.98	128.23	49.94	-11.65
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	555.51	27.93	49.54	51.71	40.1
Gross Profit, 3 Yr. CAGR %	73.84	32.56	43.56	59.02	45.12
EBITDA, 3 Yr. CAGR %	14.25	47.87	42.46	64.23	42.08
EBITA, 3 Yr. CAGR %	14.07	47.89	42.44	64.34	42.09
EBIT, 3 Yr. CAGR %	14.07	47.36	28.1	55.01	36.28
Earnings From Cont. Operations, 3 Yr. CAGR %	5.11	37.62	-1.61	60.71	37.15
Net Income, 3 Yr. CAGR %	5.11	37.62	-1.61	60.71	37.15
Normalized Net Income, 3 Yr. CAGR %	15.73	46.7	29.74	58.87	39.22
Diluted EPS Before Extra, 3 Yr. CAGR %	3.75	35.72	-3.91	52.41	30.84
Accounts Receivable, 3 Yr. CAGR %	-	0.8	102.89	113.55	127.14
Inventory, 3 Yr. CAGR %	419.87	51.51	49.83	35.41	76.11
Net Property, Plant and Equip., 3 Yr. CAGR %	153.03	53.31	205.4	-3.4	-6.34
Total Assets, 3 Yr. CAGR %	57.86	49.52	34.7	52.99	43.24
Tangible Book Value, 3 Yr. CAGR %	59.7	45.14	4.55	40.28	45.34
Common Equity, 3 Yr. CAGR %	59.7	50.79	31.75	52.09	47
Cash From Operations, 3 Yr. CAGR %	32.17	49.67	47.19	58.37	21.6
Capital Expenditures, 3 Yr. CAGR %	123.04	15.14	2.52K	-18.34	-82.05
Levered Free Cash Flow, 3 Yr. CAGR %	44.9	57.64	96.42	68.51	24.08
Unlevered Free Cash Flow, 3 Yr. CAGR %	44.9	57.64	96.42	68.51	24.08
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	280.39	36.89	37.68
Gross Profit, 5 Yr. CAGR %	55.09	69.68	67.11	42.96	41.72
EBITDA, 5 Yr. CAGR %	23.05	40.79	27.69	48.85	48.17
EBITA, 5 Yr. CAGR %	22.9	40.68	27.6	48.85	48.2
EBIT, 5 Yr. CAGR %	22.9	40.38	19.72	43.72	44.23
Earnings From Cont. Operations, 5 Yr. CAGR %	16.92	35.17	16	38.75	23.37
Net Income, 5 Yr. CAGR %	16.92	35.17	16	38.75	23.37
Normalized Net Income, 5 Yr. CAGR %	24.61	41.73	21.91	44.6	46.49
Diluted EPS Before Extra, 5 Yr. CAGR %	11.15	28.44	13.72	34.29	18.8
Accounts Receivable, 5 Yr. CAGR %	-	-	-	44.11	81.49
Inventory, 5 Yr. CAGR %	-	-	208.47	58.45	51.54
Net Property, Plant and Equip., 5 Yr. CAGR %	74.72	80.01	72.08	28.99	86.99
Total Assets, 5 Yr. CAGR %	41.64	34.48	50.72	49.93	41.83
Tangible Book Value, 5 Yr. CAGR %	39.39	27.04	30.72	45.48	37.14
Common Equity, 5 Yr. CAGR %	39.39	29.98	50.17	52.7	41.27
Cash From Operations, 5 Yr. CAGR %	27.44	53.22	40.59	47.27	35.89
Capital Expenditures, 5 Yr. CAGR %	60.43	-	364.29	96.46	39.45
Levered Free Cash Flow, 5 Yr. CAGR %	31.34	65.73	73.78	54.51	42.69
Unlevered Free Cash Flow, 5 Yr. CAGR %	31.34	65.73	73.78	54.51	42.69